Merck Soars On Cancer Vaccine Trial Win With Moderna, More Upside Ahead (NYSE:MRK)
· seekingalpha.com
Merck & Co., Inc. hits all-time highs on positive Phase 3 melanoma vaccine data with Moderna. Click for this MRK update.
Freelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various formats including articles, blogs, em...